VIP and breast cancer
- PMID: 9928023
- DOI: 10.1111/j.1749-6632.1998.tb11189.x
VIP and breast cancer
Abstract
VIP1 receptors are present in breast cancer cells. VIP elevates the cAMP and stimulates nuclear oncogene expression in MCF-7 cells. VIPhybrid is a VIP receptor antagonist that inhibits breast cancer proliferation. A VIP analog has been developed for imaging breast tumors. Therefore VIP1 receptors may be utilized for the early detection and treatment of breast cancer.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
